Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Aceragen USD 17.86M 3.56M 2023-03
Agios Pharmaceuticals USD 67.96M 9.53M 2023-12
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amgen USD 18.39B 1.44B 2023-12
Biogen USD 3.43B 1.59B 2023-12
BioMarin Pharmaceutical USD 1.18B 13.8M 2023-12
Bluebird Bio USD 158.96M 23.94M 2023-09
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Exelixis USD 376.82M 37.2M 2023-09
Gilead Sciences USD 11.28B 665M 2023-12
Incyte USD 1.24B 115.7M 2023-12
Ionis Pharmaceuticals USD 448.09M 43.88M 2023-12
Lumos Pharma USD 6.12M 429K 2023-09
Merck USD 23.09B 300M 2023-09
Moderna USD 3.02B 1.37B 2023-12
Nektar Therapeutics USD 52.11M 1.42M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
PTC Therapeutics USD 603.1M 110.98M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Sarepta Therapeutics USD 450.74M 47.91M 2023-09
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Incyte Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.